| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And President | CEO, President And Secretary | CEO, President &Secretary +1 more
1 company
Mehta Vimal is a CEO And President at BioXcel Therapeutics, Inc.. Recent SEC Form 4 filings include 21 buys and 0 sells.
Estimated insider holdings value: $47K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2019 | BTAI Bioxcel Therapeutics, Inc. | CEO, President And Secretary | Buy | 974 | $8.89 | $8,658.86 | +10.8% | |
| Aug 15, 2019 | BTAI Bioxcel Therapeutics, Inc. | CEO, President &Secretary | Buy | 2,983 | $8.64 | $25,780.27 | +24.1% | |
| Aug 13, 2019 | BTAI Bioxcel Therapeutics, Inc. | CEO, President &Secretary | Buy | 1,000 | $8.75 | $8,750.00 | +20.0% | |
| Dec 14, 2018 | BTAI Bioxcel Therapeutics, Inc. | CEO, President, Secretary | Buy | 2,000 | $4.38 | $8,766.00 | +9.9% | |
| Dec 4, 2018 | BTAI Bioxcel Therapeutics, Inc. | CEO, President, Secretary | Buy | 1,000 | $5.12 | $5,120.00 | +22.2% | |
| Dec 3, 2018 | BTAI Bioxcel Therapeutics, Inc. | CEO, President, Secretary | Buy | 1,000 | $5.17 | $5,165.00 | +15.6% | |
| Nov 30, 2018 | BTAI Bioxcel Therapeutics, Inc. | CEO, President, Secretary | Buy | 1,000 | $5.10 | $5,104.00 | +62.5% | |
| Mar 12, 2018 | BTAI Bioxcel Therapeutics, Inc. | CEO, President And Secretary | Buy | 2,000 | $11.00 | $22,000.00 | New |